Alzheimer's Disease 'Game Changer' as Progression Slowed With Immunotherapy
"We can alter the course of this devastating disease and slow it down," scientists at Emory University told Newsweek.
Stay updated with breaking news from Todd Golde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"We can alter the course of this devastating disease and slow it down," scientists at Emory University told Newsweek.
Two Alzheimer's drugs have hit the market in the past year and a half: the first treatment since 2003, and the first looking to target the cause.
Emory faculty and staff are frequently recognized for their work locally, nationally and internationally. Read a sampling of recent accolades, including awards for professional contributions and leadership appointments.
Emory University has named Todd E. Golde, MD, PhD, the new director of the Emory Center for Neurodegenerative Disease in the Goizueta Institute @ Emory Brain Health.